← Evidence map

ReviewNature reviews. Clinical oncology2013

Appraising iniparib, the PARP inhibitor that never was--what must we learn?

Joaquin Mateo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 24129347